Stay updated on Pembrolizumab for Leukoplakia Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Leukoplakia Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Leukoplakia Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2 on the page.
    Difference
    0.1%
    Check dated 2026-04-16T09:59:20.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Added revision v3.5.0 and removed revision v3.4.3 from the page.
    Difference
    0.1%
    Check dated 2026-03-25T20:19:10.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.4.3 replaces v3.4.2. This appears to be a metadata/versioning update with no visible changes to study details or page content.
    Difference
    0.1%
    Check dated 2026-03-11T16:22:33.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Revision: v3.4.2 added and a general funding-status notice was removed; these site-wide changes do not affect study content or participation. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T05:43:35.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Added a global site notice about a lapse in government funding and the NIH Clinical Center's operating status, and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T04:25:09.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added a glossary toggle and introduced the labels 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'. The revision now shows v3.4.0 and the older labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.
    Difference
    0.2%
    Check dated 2026-01-28T02:38:06.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Leukoplakia Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Leukoplakia Clinical Trial page.